help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by LEBECQUE, P.
Right arrow Articles by CASSIMAN, J.-J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by LEBECQUE, P.
Right arrow Articles by CASSIMAN, J.-J.

Am. J. Respir. Crit. Care Med., Volume 165, Number 6, March 2002, 757-761

Mutations of the Cystic Fibrosis Gene and Intermediate Sweat Chloride Levels in Children

PATRICK LEBECQUE, TERESINHA LEAL, CHRISTIANE DE BOECK, MARTINE JASPERS, HARRY CUPPENS, and JEAN-JACQUES CASSIMAN

Department of Pediatrics, Center for Human Genetics, Gasthuisberg, Katholieke Universiteit te Leuven, Leuven, Belgium; and Departments of Pediatrics and Medical Biology, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium

The incidence of mutations of the cystic fibrosis transmembrane conductance regulator (CFTR) gene in children with intermediate sweat chloride levels is unknown. The results of 2,349 sweat tests performed at two Belgian university hospitals were reviewed. Intermediate chloride concentrations were observed in 98 subjects (4.2%), 68 being younger than 18 years of age. Forty-three children could be traced and their parents agreed to take part in the study. Exhaustive analysis of the CFTR gene disclosed a total of 24 putative mutations (27.9%). Three subjects were found to carry only one CFTR mutation, whereas 10 harbored one mutation on both CFTR genes. These 10 children were investigated in detail. At the time of writing, the mean age (±SD) of this group is 8.9 years (±4.2 years). Nine children are pancreatic sufficient. Three have been asymptomatic for more than two years, whereas the others display, to different degrees, clinical features suggestive of CF. The sweat chloride concentration is slightly higher in this group (39.4 ± 5.4 mM) than in subjects without CFTR mutation (35.2 ± 4.4 mM, p < 0.05). The nasal potential difference was abnormal in five of the nine subjects tested. In this study, 23% of children displaying intermediate sweat chloride levels were found to carry a putative mutation on both CFTR genes.




This article has been cited by other articles:


Home page
 ThoraxHome page
C Goubau, M Wilschanski, V Skalicka, P Lebecque, K W Southern, I Sermet, A Munck, N Derichs, P G Middleton, L Hjelte, et al.
Phenotypic characterisation of patients with intermediate sweat chloride values: towards validation of the European diagnostic algorithm for cystic fibrosis
Thorax, August 1, 2009; 64(8): 683 - 691.
[Abstract] [Full Text] [PDF]

Home page
 ThoraxHome page
B Tummler, F Stanke, I Bronsveld, H Veeze, and M Ballmann
Transient correction of the basic defect in sweat glands in an individual with cystic fibrosis carrying the complex CFTR allele F508del-R553Q
Thorax, February 1, 2009; 64(2): 179 - 180.
[Abstract] [Full Text] [PDF]

Home page
 ThoraxHome page
L. Naehrlich
Sweat testing in CF
Thorax, May 1, 2007; 62(5): 462 - 462.
[Full Text] [PDF]

Home page
 ThoraxHome page
J K Quint, L Ward, A G Davison, and C. A De Boeck
Previously undiagnosed obesity hypoventilation syndrome
Thorax, May 1, 2007; 62(5): 462 - 463.
[Full Text] [PDF]

Home page
 PediatricsHome page
R. Giusti, A. Badgwell, A. D. Iglesias, and and the New York State Cystic Fibrosis Newborn Scr
New York State Cystic Fibrosis Consortium: The First 2.5 Years of Experience With Cystic Fibrosis Newborn Screening in an Ethnically Diverse Population
Pediatrics, February 1, 2007; 119(2): e460 - e467.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
T. M. Ziedalski, P. N. Kao, N. R. Henig, S. S. Jacobs, and S. J. Ruoss
Prospective analysis of cystic fibrosis transmembrane regulator mutations in adults with bronchiectasis or pulmonary nontuberculous mycobacterial infection.
Chest, October 1, 2006; 130(4): 995 - 1002.
[Abstract] [Full Text] [PDF]

Home page
 ThoraxHome page
K De Boeck, M Wilschanski, C Castellani, C Taylor, H Cuppens, J Dodge, M Sinaasappel, and on behalf of the Diagnostic Working Group
Cystic fibrosis: terminology and diagnostic algorithms
Thorax, July 1, 2006; 61(7): 627 - 635.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
H. L. Wallace, P. M. Barker, and K. W. Southern
Nasal Airway Ion Transport and Lung Function in Young People with Cystic Fibrosis
Am. J. Respir. Crit. Care Med., September 1, 2003; 168(5): 594 - 600.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
A. Bush, C. Wallis, P. Lebecque, and K. De Boeck
Mutations of CFTR gene and intermediate sweat chloride levels
Am. J. Respir. Crit. Care Med., June 1, 2003; 167(11): 1577 - 1578.
[Full Text]

Home page
 Am. J. Respir. Crit. Care Med.Home page
M. J. Tobin
Pediatrics, Surfactant, and Cystic Fibrosis in AJRCCM 2002
Am. J. Respir. Crit. Care Med., February 1, 2003; 167(3): 333 - 344.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 2002 American Thoracic Society 		  Red In Translatin